PL
RGEN icon

Polianta Ltd’s Repligen RGEN Stock Holding History

Polianta Ltd’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,600
Closed -$1.06M – 95
2020
Q2 		$1.06M Buy
+8,600
New +$1.01M 0.69% 21

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Polianta Ltd's RGEN Position: Q3 2020 in Review

Polianta Ltd sold out of Repligen (RGEN) in Q3 2020, closing a stake of 8,600 shares — an estimated $1.06M sold.

Polianta Ltd first reported a position in RGEN in Q2 2020 and held it in 1 quarter. The position peaked at $1.06M in Q2 2020. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.

  • Polianta Ltd reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
  • Polianta Ltd sold 8,600 Repligen shares in Q3 2020, an estimated $1.06M.
  • Polianta Ltd first reported a position in Repligen in Q2 2020 and held it in 1 quarter.
  • Polianta Ltd's Repligen position peaked at $1.06M in Q2 2020.
  • 390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.

Based on Polianta Ltd's 13F filing for Q3 2020, filed 7 Oct 2020.